Lv41
530 积分 2025-04-22 加入
TMEM199 promotes PD-L1 expression and tumor immune evasion by activating the recycling of IFNGR1/2
1小时前
待确认
Regorafenib enhances anti-PDCD1/PD-1 therapeutic efficacy in colorectal cancer by promoting SQSTM1/p62-mediated CD274/PD-L1 degradation
1小时前
待确认
ERRα-ETV5 axis drives PD-L1 upregulation and immune escape in gallbladder cancer
1小时前
待确认
TRIM11 potentiates antitumor immunity via inhibition of the IFN-γ/PD-L1 axis
3小时前
待确认
Hijacking ERAD for targeted degradation of transmembrane proteins
3小时前
待确认
Emerging Biomaterials Blocking PD‐1/PD‐L1 Pathway for Cancer Therapy
3小时前
待确认
Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
3小时前
待确认
Ginsenoside Rg3 improves atezolizumab immune checkpoint therapy in triple-negative breast cancer by targeting FUT8-mediated PD-L1 N-glycosylation
4天前
已完结
The interplay between cytokines and immune checkpoints in breast cancer therapy
5天前
已完结
Cancer stem cells orchestrate immune evasion through extracellular vesicle-mediated non-canonical signaling pathways
5天前
已完结
皖公网安备34019202002308
